Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Primary objective :
To compare the combination of S-1 and oxaliplatin(SOX) to the combination of capecitabine and
oxaliplatin(COX) therapy for advanced or metastatic colorectal carcinoma.
Secondary objectives :
1. To evaluate and compare the efficacy (overall survival and response rate) in the two
treatment groups.
2. To evaluate and compare the quality of life of the patients and safety profiles of the
two treatment groups.
Phase:
Phase 3
Details
Lead Sponsor:
Samsung Medical Center
Collaborators:
Asan Medical Center Chonnam National University Hospital Gachon University Gil Medical Center National Cancer Center, Korea Seoul National University Bundang Hospital Seoul National University Hospital Yonsei University